Literature DB >> 21616652

Glycosylation, galectins and cellular signaling.

Cecile Boscher1, James W Dennis, Ivan R Nabi.   

Abstract

Glycosylation is a common posttranslational modification of proteins and lipids of the secretory pathway that generates binding sites for galactose-specific lectins or galectins. Branching of Asn-linked (N-)glycans by the N-acetylglucosaminyltransferases (Mgat genes) increases affinity for galectins. Both tissue-specific expression of the enzymes and the metabolic supply of sugar-nucleotides to the ER and Golgi regulate glycan distribution while protein sequences specify NXS/T site multiplicity, providing metabolic and genetic contributions to galectin-glycoprotein interactions. Galectins cross-link glycoproteins forming dynamic microdomains or lattices that regulate various mediators of cell adhesion, migration, proliferation, survival and differentiation. There are a similar number of galactose-specific galectins in C. elegans and humans, but expression of higher-affinity branched N-glycans are a more recent feature of vertebrate evolution. Galectins might be considered a reading code for repetition of the minimal units of binding [Gal(NAc)β1-3/4GlcNAc] and NXS/T site multiplicity in proteins. The rapidly evolving and structurally complex Golgi modifications to surface receptors are interpreted through affinity for the lattice, which regulates receptor levels as a function of the cellular environment, and thereby the probability of various cell fates. Many important questions remain concerning the regulation of the galectins, the glycan ligands and lattice interaction with other membrane domains and endocytic pathways.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21616652     DOI: 10.1016/j.ceb.2011.05.001

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  124 in total

1.  Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching.

Authors:  Huabei Guo; Alison Nairn; Mitche dela Rosa; Tamas Nagy; Shaying Zhao; Kelley Moremen; Michael Pierce
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis.

Authors:  Ruben T Almaraz; Yuan Tian; Rahul Bhattarcharya; Elaine Tan; Shih-Hsun Chen; Matthew R Dallas; Li Chen; Zhen Zhang; Hui Zhang; Konstantinos Konstantopoulos; Kevin J Yarema
Journal:  Mol Cell Proteomics       Date:  2012-03-28       Impact factor: 5.911

Review 3.  Glycosylation of solute carriers: mechanisms and functional consequences.

Authors:  Nis Borbye Pedersen; Michael C Carlsson; Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2015-09-18       Impact factor: 3.657

4.  Synthesis, Processing, and Function of N-glycans in N-glycoproteins.

Authors:  Erhard Bieberich
Journal:  Adv Neurobiol       Date:  2014

5.  Identification of methyllysine peptides binding to chromobox protein homolog 6 chromodomain in the human proteome.

Authors:  Nan Li; Richard S L Stein; Wei He; Elizabeth Komives; Wei Wang
Journal:  Mol Cell Proteomics       Date:  2013-07-10       Impact factor: 5.911

Review 6.  Nuclear transport of galectin-3 and its therapeutic implications.

Authors:  Tatsuyoshi Funasaka; Avraham Raz; Pratima Nangia-Makker
Journal:  Semin Cancer Biol       Date:  2014-03-19       Impact factor: 15.707

7.  Comparative analysis of carbohydrate binding properties of Sambucus nigra lectins and ribosome-inactivating proteins.

Authors:  Chenjing Shang; Els J M Van Damme
Journal:  Glycoconj J       Date:  2014-05-23       Impact factor: 2.916

Review 8.  Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update.

Authors:  Vanessa Leiria Campo; Marcelo Fiori Marchiori; Lílian Cataldi Rodrigues; Marcelo Dias-Baruffi
Journal:  Glycoconj J       Date:  2016-08-15       Impact factor: 2.916

9.  Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells.

Authors:  Cécile Boscher; Yu Zi Zheng; Ramya Lakshminarayan; Ludger Johannes; James W Dennis; Leonard J Foster; Ivan R Nabi
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

Review 10.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.